A Booster Study of S-268019 in Japan-2 (COVID-19)
Phase 3
- Conditions
- Prevention of COVID-19
- Registration Number
- JPRN-jRCT2031210613
- Lead Sponsor
- agata Tsutae
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Participant must be >= 20 years of age inclusive, at the time of signing the informed consent.
Participant who have received 2 doses of SARS-CoV-2 vaccine (Adults:only SPIKEVAX, Older adults: COMIRNATY or SPIKEVAX) and 6 months or more and 8 months or less after second dose.
Exclusion Criteria
Positive SARS-CoV-2 antigen test result at Screening.
A known history of SARS-CoV-2 infection as determined by medical interview before study intervention.
Participant has a contraindication to IM injections or blood draws.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method